Author Question: The primary care NP sees a woman who has been taking HT for menopausal symptoms for 3 years. The NP ... (Read 70 times)

bucstennis@aim.com

  • Hero Member
  • *****
  • Posts: 532
The primary care NP sees a woman who has been taking HT for menopausal symptoms for 3 years. The NP decreases the dosage, and several weeks later, the woman calls to report having several hot flashes each day. The NP should:
 
  a. increase the HT dose.
  b. discontinue HT.
  c. recommend black cohosh to alleviate symptoms.
  d. reassure her that these symptoms will diminish over time.

Question 2

A patient comes to the clinic complaining of low back pain unrelieved by NSAIDs. The patient has a history of angle-closure glaucoma and renal disease. The primary care NP should prescribe:
 
  a. tizanidine (Zanaflex).
  b. metaxalone (Skelaxin).
  c. acetaminophen (Tylenol).
  d. cyclobenzaprine (Flexeril).



lindahyatt42

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

A
The Women's Health Initiative results indicate that HT use for 3 to 5 years is safe and recommend slow weaning after women review HT with their providers at annual visits. If symptoms recur, the dose should be increased until symptoms improve.

Answer to Question 2

B
Metaxalone may be taken by patients with angle-closure glaucoma and is metabolized by the liver, so it is safe for this patient. Tizanidine should not be given to patients with renal disease because clearance may be reduced by more than 50. After using NSAIDs with no relief, recommendations are to change to a muscle relaxant. Cyclobenzaprine is not recommended in patients with glaucoma.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

For a complete list of videos, visit our video library